ArriVent BioPharma Ratios (2023-2026) | AVBP

Ratios Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 245.47M318.35M300.78M283.83M245.22M242.50M298.03M329.86M341.23M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.52-0.63-0.78-0.57-99.18-2.26-0.91-1.35-231.09-1.15
Times Interest Earned (Quarter) -0.52-0.63-0.78-0.57-99.18-2.26-0.91-1.35-231.09-1.15
Valuation
Enterprise Value (Quarter) -124.30M-317.39M-298.67M-282.86M-218.86M-176.08M-235.69M-492.99M-312.82M-326.38M
Return Ratios
Return on Capital Employed (Quarter) -35.28%-28.15%-32.81%-35.38%-60.45%-66.56%-58.75%-58.42%-49.61%
Return on Assets (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%